Cargando…

Oncofertility counselling in premenopausal women with HER2-positive breast cancer

A complete oncofertility counselling should be offered to all premenopausal patients before the administration of anticancer treatments. This important discussion is a crucial step for allowing them to take fully informed decisions about the proposed therapy and its potential long-term consequences...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lambertini, Matteo, Demeestere, Isabelle, Viglietti, Giulia, de Azambuja, Evandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398182/ https://www.ncbi.nlm.nih.gov/pubmed/30847021 http://dx.doi.org/10.18632/oncotarget.26565

Ejemplares similares

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?
por: Lambertini, Matteo, et al.
Publicado: (2018)

Pregnancies in young women with diagnosis and treatment of HER2-positive breast cancer
por: Lambertini, Matteo, et al.
Publicado: (2019)

Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
por: Agostinetto, Elisa, et al.
Publicado: (2023)

Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients
por: Arecco, Luca, et al.
Publicado: (2020)

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
por: Kourie, Hampig Raphael, et al.
Publicado: (2017)

Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
por: Lambertini, Matteo, et al.
Publicado: (2019)

Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis
por: Poggio, Francesca, et al.
Publicado: (2018)

Twenty years of anti-HER2 therapy-associated cardiotoxicity
por: Pondé, Noam F, et al.
Publicado: (2016)

Awareness and practices of Arab oncologists towards oncofertility in young women with cancer
por: Kassem, Loay, et al.
Publicado: (2022)

Oncofertility and COVID-19—cancer does not wait
por: Sirohi, Bhawna, et al.
Publicado: (2020)

Oncofertility and Reproductive Counseling in Patients with Breast Cancer: A Retrospective Study
por: Zaami, Simona, et al.
Publicado: (2022)

The role of Indian gynecologists in oncofertility care and counselling
por: Mahajan, Nalini, et al.
Publicado: (2016)

Proceedings of the Oncofertility Congress of the “Freezing Ovarian Tissue and Oocytes” (FOTO) Consortium Brussels
por: Dolmans, Marie-Madeleine, et al.
Publicado: (2022)

How I treat metastatic triple-negative breast cancer
por: Caparica, Rafael, et al.
Publicado: (2019)

Practical issues and research trends of oncofertility in gynecologic cancer
por: Park, Jeong-Yeol
Publicado: (2021)

Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do?
por: Poggio, Francesca, et al.
Publicado: (2018)

Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis
por: Brandão, Mariana, et al.
Publicado: (2020)

Oncofertility: Pharmacological Protection and Immature Testicular Tissue (ITT)-Based Strategies for Prepubertal and Adolescent Male Cancer Patients
por: Ntemou, Elissavet, et al.
Publicado: (2019)

Impact of Breast Cancer and Germline BRCA Pathogenic Variants on Fertility Preservation in Young Women
por: Prokurotaite, Elze, et al.
Publicado: (2023)

Is there a role for immunotherapy in HER2-positive breast cancer?
por: Holgado, Esther, et al.
Publicado: (2018)

PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
por: Agostinetto, Elisa, et al.
Publicado: (2022)

Contraceptive Use in Premenopausal Women With Early Breast Cancer
por: Lambertini, Matteo, et al.
Publicado: (2022)

Developments in the Management of Metastatic HER2-Positive Breast Cancer: A Review
por: Lebert, Julie, et al.
Publicado: (2022)

The Exciting New Field of HER2-Low Breast Cancer Treatment
por: Eiger, Daniel, et al.
Publicado: (2021)

Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives
por: Caparica, Rafael, et al.
Publicado: (2019)

Risk factors for the development of brain metastases in patients with HER2-positive breast cancer
por: Maurer, Christian, et al.
Publicado: (2018)

Premenopausal Reproductive Health Modulates Future Cardiovascular Risk – Comparative Evidence from Monkeys and Women   
por: Kaplan, Jay R., et al.
Publicado: (2017)

Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
por: Snoj, Natasa, et al.
Publicado: (2009)

Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer
por: Anderson, Richard A., et al.
Publicado: (2022)

A multidisciplinary pediatric oncofertility team improves fertility preservation and counseling across 7 years
por: Ligon, John A., et al.
Publicado: (2022)

Oncofertility in sarcoma patients
por: Lopategui, Diana M., et al.
Publicado: (2017)

Pediatric oncofertility: an update
por: Lau, Glen A., et al.
Publicado: (2020)

Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast Cancer
por: Kabirian, Rayan, et al.
Publicado: (2023)

HER2-Low Breast Cancer: Molecular Characteristics and Prognosis
por: Agostinetto, Elisa, et al.
Publicado: (2021)

CDK4/6 inhibitors as adjuvant treatment for hormone receptor-positive, HER2-negative early breast cancer: a systematic review and meta-analysis
por: Agostinetto, E., et al.
Publicado: (2021)

Access to information and oncofertility consultation for young women with breast cancer: a population-based study
por: Martinet-Kosinski, Florian, et al.
Publicado: (2023)

How we treat patients with metastatic HER2-positive breast cancer
por: Nader-Marta, G., et al.
Publicado: (2022)

Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial
por: Lambertini, Matteo, et al.
Publicado: (2020)

Oncofertility: A Global Perspective
Publicado: (2020)

Oncofertility in Islam: The Malaysian Perspective
por: Ahmad, Mohd Faizal, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_49b2uhkc96h3ipvvc310ufunts